Zhengyang Quan

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Beijing University of Chinese Medicine(Current)

Zhengyang Quan is an author at Beijing University of Chinese Medicine specializing in pharmacology, liver toxicity mechanisms, and cell viability assays.

Publications per year

2020–2021

Publications

Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment

Yong Li, Yiqun Li, Dengke Li et al. · Frontiers in Pharmacology · 2020 · 22 citations · Full text

Medicine, Oncology, Pharmacology +16

Exploration of components and mechanisms of Polygoni Multiflori Radix-induced hepatotoxicity using siRNA -mediated CYP3A4 or UGT1A1 knockdown liver cells

HU Yinghuan, Dengke Li, Zhengyang Quan et al. · Journal of Ethnopharmacology · 2021 · 22 citations

Pharmacy, Pharmacology, Toxicology +14

Inhibition of CYP3A4 enhances aloe-emodin induced hepatocyte injury

HU Yinghuan, Zhengyang Quan, Dengke Li et al. · Toxicology in Vitro · 2021 · 15 citations

Veterinary Medicine, Biochemistry, Pharmacology +12

1–3 of 3